Status:
COMPLETED
Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
Lead Sponsor:
CENTOGENE GmbH Rostock
Collaborating Sponsors:
Shire Human Genetic Therapies, Inc.
Conditions:
Fabry Disease
Cerebrovascular Accident
Eligibility:
All Genders
18-55 years
Brief Summary
New studies indicate that in about 1 - 2 percent of the younger stroke patients the cause could have been an undiagnosed genetic disease, the so called Fabry disease. In this case certain fat molecule...
Detailed Description
In a group of young stroke patients with diagnosed Fabry disease the stroke rehabilitation will be investigated during different prophylactic therapeutic approaches. In this study the investigator wil...
Eligibility Criteria
Inclusion
- Adult patients (18 - 55 years of age) with an acute cerebrovascular event (CVE) of any etiology defined as patients having an ischemic stroke or transient ischemic attack
- Genetic diagnosis (a-galactosidase defect)of Fabry disease
- Written informed consent from patient
Exclusion
- No proven Fabry disease
- Participating in an other clinical trial with any investigational new drug or medical device
- Contraindication to any of the diagnostic procedures like e.g. MRI investigation
- Patient has been pretreated with Enzyme Replacement Therapy at the date of informed consent of sifap2
Key Trial Info
Start Date :
July 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00413595
Start Date
July 1 2007
End Date
December 1 2019
Last Update
April 12 2021
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum für Neurologie
Graz, Austria, A-8036
2
Department of Neurology, University Hospital Sestre Milosrdnice
Zagreb, Croatia, 10000
3
Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires
Lyon, France, F-69003
4
Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university
Tbilisi, Georgia, 0179